Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
33.84
-2.37 (-6.55%)
At close: Apr 1, 2025, 4:00 PM
34.70
+0.86 (2.55%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Ultragenyx Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
173.73213.58132.94307.58713.53
Upgrade
Short-Term Investments
436.3363.63614.82432.61488.01
Upgrade
Cash & Short-Term Investments
610.03577.21747.76740.21,202
Upgrade
Cash Growth
5.68%-22.81%1.02%-38.40%59.09%
Upgrade
Accounts Receivable
121.873.3940.4528.4323.09
Upgrade
Other Receivables
1.81.16.4169.6
Upgrade
Receivables
123.674.4946.8544.4332.69
Upgrade
Inventory
45.0133.9726.7716.2313.05
Upgrade
Prepaid Expenses
31.6844.51-55.7537.18
Upgrade
Restricted Cash
6.812.010.86-10.85
Upgrade
Other Current Assets
--61.66--
Upgrade
Total Current Assets
817.12732.18883.9856.61,295
Upgrade
Property, Plant & Equipment
291.43314.47285.73176.18114.04
Upgrade
Long-Term Investments
135199.9148.97293.86165.88
Upgrade
Goodwill
44.4144.4144.4144.4144.41
Upgrade
Other Intangible Assets
178.31166.27160.11130.79131.11
Upgrade
Other Long-Term Assets
37.1833.7922.3420.566.71
Upgrade
Total Assets
1,5031,4911,5451,5221,760
Upgrade
Accounts Payable
38.7642.1143.2717.1412.92
Upgrade
Accrued Expenses
240.97196.49204.68145.56108.49
Upgrade
Current Portion of Long-Term Debt
49.8529.24---
Upgrade
Current Portion of Leases
10.312.611.7811.078.98
Upgrade
Current Unearned Revenue
--1.487.6159.22
Upgrade
Other Current Liabilities
4.28----
Upgrade
Total Current Liabilities
344.15280.44261.21181.37189.61
Upgrade
Long-Term Debt
819.82862.33875.44351.79335.67
Upgrade
Long-Term Leases
30.0430.5719.8130.939.25
Upgrade
Long-Term Unearned Revenue
---1.477.35
Upgrade
Long-Term Deferred Tax Liabilities
30.0630.0631.6733.3133.31
Upgrade
Other Long-Term Liabilities
17.0812.214.821.01-
Upgrade
Total Liabilities
1,2411,2161,193599.84605.18
Upgrade
Common Stock
0.090.080.070.070.07
Upgrade
Additional Paid-In Capital
4,2133,6623,1402,9972,773
Upgrade
Retained Earnings
-3,957-3,388-2,781-2,074-1,620
Upgrade
Treasury Stock
-3.59-0.43---
Upgrade
Comprehensive Income & Other
2.951.08-6.57-1.40.69
Upgrade
Total Common Equity
255.3275.41352.49922.561,154
Upgrade
Minority Interest
7----
Upgrade
Shareholders' Equity
262.3275.41352.49922.561,154
Upgrade
Total Liabilities & Equity
1,5031,4911,5451,5221,760
Upgrade
Total Debt
910.01934.74907.03393.76383.89
Upgrade
Net Cash (Debt)
-164.98-157.63-10.3605.37828.15
Upgrade
Net Cash Growth
----26.90%102.96%
Upgrade
Net Cash Per Share
-1.82-2.14-0.158.9313.61
Upgrade
Filing Date Shares Outstanding
92.582.3470.2269.3866.95
Upgrade
Total Common Shares Outstanding
92.4882.3270.269.3466.82
Upgrade
Working Capital
472.97451.75622.69675.241,106
Upgrade
Book Value Per Share
2.763.355.0213.3017.28
Upgrade
Tangible Book Value
32.5864.74147.98747.37978.86
Upgrade
Tangible Book Value Per Share
0.350.792.1110.7814.65
Upgrade
Land
16.6216.6216.6215.4911.72
Upgrade
Buildings
181.58181.362.8--
Upgrade
Machinery
120.41116.2670.2854.3141.63
Upgrade
Construction In Progress
--189.4576.8517.65
Upgrade
Leasehold Improvements
58.0258.6843.9444.0839.36
Upgrade
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q